Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

Cidara Therapeutics Inc

Start price
Target price
Perf. (%)
€1.58
07.02.23
€1.00
07.02.24
-5.06%
18.02.23

Probably not worthwhile Investment
Below average Management
Bad culture
buy
Cidara Therapeutics Inc

Start price
Target price
Perf. (%)
€0.78
21.09.22
€3.00
30.04.23
87.12%
06.02.23

Could be very worthwhile Investment >20% year
buy
Riot Blockchain Inc.

Start price
Target price
Perf. (%)
€6.05
22.01.23
-
22.01.24
3.80%
05.02.23

Could be very worthwhile Investment >20% year
Riot Blockchain Inc.

Start price
Target price
Perf. (%)
€4.62
16.11.22
€1.00
16.11.23
26.73%
23.01.23

Little Investments for future growth
No Innovation
Significant cyclical dependencies
Very bad culture
Riot Blockchain Inc.

Start price
Target price
Perf. (%)
€5.52
13.01.23
-
13.01.24
9.62%
21.01.23

Risky Investment
buy
Purple Biotech Ltd. ADR

Start price
Target price
Perf. (%)
€3.52
21.01.21
€60.00
21.01.23
-54.26%
21.01.23

Could be very worthwhile Investment >20% year
buy
Evoke Pharma Inc.

Start price
Target price
Perf. (%)
€28.25
21.01.21
€120.00
21.01.23
-86.83%
21.01.23

Could be very worthwhile Investment >20% year
Riot Blockchain Inc.

Start price
Target price
Perf. (%)
€3.98
12.12.22
-
12.12.23
1.61%
09.01.23

Could be worthwhile Investment >10% per year
Very high cyclical dependencies
buy
Cardiff Oncology Inc.

Start price
Target price
Perf. (%)
€1.24
17.11.22
-
17.11.23
0.48%
26.12.22

Risky Investment
buy
Euromedis Groupe

Start price
Target price
Perf. (%)
€10.64
24.12.21
-
24.12.22
-57.99%
25.12.22

Could be worthwhile Investment >10% per year
buy
Aptevo Therapeutics Inc.

Start price
Target price
Perf. (%)
€5.39
12.12.22
€7.00
12.12.23
-60.16%
24.12.22

Could be very worthwhile Investment >20% year
Very capable Management
Very good company culture
Little innovation
HTG Molecular Diagnostics Inc.

Start price
Target price
Perf. (%)
€19.20
12.12.22
€0.000
12.12.23
-63.50%
15.12.22

Capable Management
Risky Investment
No uniques
No Innovation
buy
Riot Blockchain Inc.

Start price
Target price
Perf. (%)
€4.13
28.11.22
-
28.11.23
-3.64%
12.12.22

Could be worthwhile Investment >10% per year
Very high cyclical dependencies
buy
BiondVax Pharmaceuticals Ltd ADR

Start price
Target price
Perf. (%)
€9.38
30.11.22
€18.00
30.11.23
8.11%
12.12.22

buy
Riot Blockchain Inc.

Start price
Target price
Perf. (%)
€4.13
28.11.22
-
28.11.23
-1.66%
10.12.22

Risky Investment
Riot Blockchain Inc.

Start price
Target price
Perf. (%)
€4.80
14.11.22
-
14.11.23
-13.88%
28.11.22

Could be worthwhile Investment >10% per year
Very high cyclical dependencies
buy
PDS Biotechnology Corp.

Start price
Target price
Perf. (%)
€6.75
14.11.22
€10.00
14.11.23
31.66%
17.11.22

Could be very worthwhile Investment >20% year
Very capable Management
Very good company culture
Few uniques
buy
Genomic Vision S.A.

Start price
Target price
Perf. (%)
€0.30
12.11.21
€0.50
12.11.22
-78.55%
13.11.22

Could be worthwhile Investment >10% per year
Riot Blockchain Inc.

Start price
Target price
Perf. (%)
€6.20
19.09.22
-
19.09.23
-18.43%
08.11.22

Could be worthwhile Investment >10% per year
Very high cyclical dependencies
buy
Mauna Kea Tech

Start price
Target price
Perf. (%)
€0.84
07.11.21
€1.10
07.11.22
-33.61%
08.11.22

Could be worthwhile Investment >10% per year
First Wave BioPharma Inc.

Start price
Target price
Perf. (%)
€8.22
15.10.22
€0.000
15.10.23
2.13%
29.10.22

Low dividend yield expected
Bad rating
ROE lower than 10% per year
Sustainability is little important
buy
Euromedis Groupe

Start price
Target price
Perf. (%)
€4.10
04.10.22
-
04.10.23
14.15%
25.10.22

Probably not worthwhile Investment
buy
aTyr Pharma Inc

Start price
Target price
Perf. (%)
€2.68
27.06.22
-
27.06.23
-12.04%
23.10.22

Could be worthwhile Investment >10% per year
buy
Riot Blockchain Inc.

Start price
Target price
Perf. (%)
€6.61
29.08.22
-
29.08.23
-10.43%
15.10.22

Could be very worthwhile Investment >20% year
buy
Cellectis SA ADR

Start price
Target price
Perf. (%)
€6.75
11.01.22
€8.00
11.01.23
-65.63%
07.10.22

Could be worthwhile Investment >10% per year